RET codon 609 mutations: a contribution for better clinical managing

Medullary thyroid carcinoma currently accounts for 5–8% of all thyroid cancers. The clinical course of this disease varies from extremely indolent tumors that can go unchanged for years to an extremely aggressive variant that is associated with a high mortality rate. As many as 75% of all medullary...

Descripción completa

Detalles Bibliográficos
Autores principales: Mian, Caterina, Sartorato, Paola, Barollo, Susi, Zane, Mariangela, Opocher, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328822/
https://www.ncbi.nlm.nih.gov/pubmed/22584703
http://dx.doi.org/10.6061/clinics/2012(Sup01)07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328822/
https://www.ncbi.nlm.nih.gov/pubmed/22584703
http://dx.doi.org/10.6061/clinics/2012(Sup01)07

Ejemplares similares